Wang Hui, Lin Danfeng, Yu Qianqian, Li Zhouqi, Lenahan Cameron, Dong Ying, Wei Qichun, Shao Anwen
Department of Medical Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Breast Surgery, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Cell Dev Biol. 2021 Jun 9;9:629150. doi: 10.3389/fcell.2021.629150. eCollection 2021.
Currently, mechanisms and therapeutic approaches have been thoroughly studied in various prevalent malignant tumors, such as breast and lung cancer. However, there is inevitable tumor progression and drug resistance. Uncovering novel treatment strategies to inhibit tumor development is important. Ferroptosis, a form of cell death associated with iron and lipid peroxidation, has drawn extensive attention. In this paper, we reviewed the underlying mechanisms of ferroptosis (i.e., iron, glutathione, and lipid metabolism) and its role in various tumors (i.e., lung cancer, liver carcinoma, breast cancer, and pancreatic cancer). Moreover, we summarized ferroptosis-related anti-tumor drugs and emphasized the potential of combined treatment of anti-tumor drugs and radiotherapy in an effort to provide novel anti-tumor treatments.
目前,在各种常见的恶性肿瘤,如乳腺癌和肺癌中,其机制和治疗方法已得到深入研究。然而,肿瘤进展和耐药性是不可避免的。探索抑制肿瘤发展的新治疗策略至关重要。铁死亡是一种与铁和脂质过氧化相关的细胞死亡形式,已引起广泛关注。在本文中,我们综述了铁死亡的潜在机制(即铁、谷胱甘肽和脂质代谢)及其在各种肿瘤(即肺癌、肝癌、乳腺癌和胰腺癌)中的作用。此外,我们总结了与铁死亡相关的抗肿瘤药物,并强调了抗肿瘤药物与放疗联合治疗的潜力,以期提供新的抗肿瘤治疗方法。